Finanicial report looks good. 13 cents share profit last quarter. What will drive this stock is their doc alerts. These are messages direct form the drug companies to Doctor's smart phones using the free or paid Epocrates drug database. The drug companies pay for this service, and it a very cost effective alternative to having drug represenatives visit the office. Many times physicians won't see the drug reps because they don't have time, but they will read the short message on their smart phones. Physicians use this to quickly check doses and drug interactions on their smart phone, before they write prescriptions.